BRUKER CORPORATION Payments for (Proceeds from) Other Investing Activities
BRUKER CORPORATION (BRKR) reported Payments for (Proceeds from) Other Investing Activities of -$4.00 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Cash Flow › Investing Activities
us-gaap:PaymentsForProceedsFromOtherInvestingActivities · last filed 2026-08-05
- BRUKER CORPORATION payments for (proceeds from) other investing activities for the quarter ending 2026-06-30 was -$3.50M, a 350.00% decline year-over-year.
- BRUKER CORPORATION payments for (proceeds from) other investing activities for the quarter ending 2026-03-31 was -$500.00K.
- BRUKER CORPORATION payments for (proceeds from) other investing activities for the quarter ending 2025-12-31 was -$7.90M.
- BRUKER CORPORATION payments for (proceeds from) other investing activities for the quarter ending 2025-09-30 was $2.70M, a 92.24% decline year-over-year.
- BRUKER CORPORATION payments for (proceeds from) other investing activities for fiscal 2025 was -$4.80M.
- BRUKER CORPORATION payments for (proceeds from) other investing activities for fiscal 2024 was -$5.90M.
- BRUKER CORPORATION payments for (proceeds from) other investing activities for fiscal 2023 was -$32.30M.
| Period end | Payments for (Proceeds from) Other Investing Activities 3 month | Payments for (Proceeds from) Other Investing Activities 6 month | Payments for (Proceeds from) Other Investing Activities 9 month | Payments for (Proceeds from) Other Investing Activities 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$3.50M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | -$4.00M 10-Q · filed 2026-08-05 | -$11.90M derived: sum of 3 quarters · filed 2026-08-05 | -$9.20M derived: sum of 4 quarters · filed 2026-08-05 |
| 2026-03-31 | -$500.00K 10-Q · filed 2026-05-07 | -$8.40M derived: sum of 2 quarters · filed 2026-05-07 | -$5.70M derived: sum of 3 quarters · filed 2026-05-07 | -$4.30M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-12-31 | -$7.90M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | -$5.20M derived: sum of 2 quarters · filed 2026-02-27 | -$3.80M derived: sum of 3 quarters · filed 2026-08-05 | -$4.80M 10-K · filed 2026-02-27 |
| 2025-09-30 | $2.70M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | $4.10M derived: sum of 2 quarters · filed 2026-08-05 | $3.10M 10-Q · filed 2025-11-05 | -$44.20M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-06-30 | $1.40M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | $400.00K 10-Q · filed 2026-08-05 | -$46.90M derived: sum of 3 quarters · filed 2026-08-05 | -$12.10M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-03-31 | -$1.00M 10-Q · filed 2026-05-07 | -$48.30M derived: sum of 2 quarters · filed 2026-05-07 | -$13.50M derived: sum of 3 quarters · filed 2026-05-07 | -$15.20M derived: sum of 4 quarters · filed 2026-05-07 |
| 2024-12-31 | -$47.30M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | -$12.50M derived: sum of 2 quarters · filed 2026-02-27 | -$14.20M derived: sum of 3 quarters · filed 2026-02-27 | -$5.90M 10-K · filed 2026-02-27 |
| 2024-09-30 | $34.80M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | $33.10M derived: sum of 2 quarters · filed 2025-11-05 | $41.40M 10-Q · filed 2025-11-05 | |
| 2024-06-30 | -$1.70M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-06 | $6.60M 10-Q · filed 2025-08-06 | ||
| 2024-03-31 | $8.30M 10-Q · filed 2025-05-07 | |||
| 2023-12-31 | -$32.30M 10-K · filed 2026-02-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Avantor, Inc. (AVTR) | United States | $10.501B | -9.72 |
| REVVITY, INC. (RVTY) | United States | $16.814B | 53.44 |
| Alamar Biosciences, Inc. (ALMR) | United States | $2.300B | |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |